CMS offers new ICD-10 resources

The Centers for Medicare & Medicaid Services (CMS) has released new educational resources to help providers with each phase of the ICD-10 implementation process.

The resources include the following:

  • Online ICD-10 Guide – a comprehensive resource to help providers implement every step of the transition from ICD-9 to ICD-10 medical codes.
  • Introduction to ICD-10 – an overview of ICD-10, in-depth steps for providers to take to prepare, and available educational resources to use along the way. 
  • Role of Clearinghouses in ICD-10 Transition– an overview of how to determine if clearinghouses offer ICD-10 transition billing/coding services.
  • Basics for Small and Rural Practices  – a resource focused on supporting small and rural practices with activities related to ICD-10 transition. 
  • ICD-10 Resources Flyer – a complete list of all available CMS resources related to ICD-10 transition; updated to include recently launched materials.

Continuing medical education (CME) and continuing education (CE) credits are available to physicians and nurses who complete ICD-10: ICD-10: A Roadmap for Small Clinical Practices and ICD-10: Small Practice Guide to a Smooth Transition, two free Medscape Education Modules that provide guidance to small practices making the transition to ICD-10.

For more information, visit the CMS ICD-10 website.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.